Top Markets
Coin of the day
VectivBio Holding AG VectivBio Holding AG

VectivBio Holding AG

VECT
Rankning i aktier #14767
VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to... VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to identifying, developing, and commercializing treatments for severe rare medical conditions. The company's primary therapeutic focus is apraglutide, a prolonged-acting synthetic peptide analog of glucagon-like peptide-2. This compound is currently in a Phase III clinical trial for individuals with short bowel syndrome-intestinal failure (SBS-IF), and is also being evaluated in a Phase II clinical trial for SBS-IF patients with colon-in-continuity anatomy. Furthermore, apraglutide is undergoing a Phase II clinical study for patients experiencing steroid-refractory gastrointestinal acute graft-versus-host disease (aGvHD). Founded in 2019, VectivBio's corporate headquarters are situated in Basel, Switzerland.
Aktiekurs
$16.85
Senast synkroniserad: 2023-07-07
Marknadsvärde
$393.50M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
CH
Handel VectivBio Holding AG (VECT)

Kategori

Historik för aktiesplit för VectivBio Holding AG (VECT)
Aktien VectivBio Holding AG (symbol: VECT) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Sep 01, 2026.
En VECT-aktie köpt före Sep 01, 2026 motsvarar nu 0 VECT-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH